As of April 19, 2025, Rani Therapeutics (RANI) has a market cap of $68.800 million USD. According to our data, Rani Therapeutics is ranked No.7852 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $68.80 M |
50.76%
|
Dec 31, 2024 | $45.64 M |
-58.73%
|
Dec 29, 2023 | $0.11 B |
-43.73%
|
Dec 30, 2022 | $0.20 B |
-63.91%
|
Dec 31, 2021 | $0.54 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Ironwood Pharmaceuticals
IRWD
|
$0.12 B |
-0.534 M
|
![]() USA
|
![]() Entera Bio
ENTX
|
$81.30 M |
-0.000 M
|
![]() Israel
|
![]() Oramed Pharmaceuticals
ORMP
|
$87.83 M |
-0.000 M
|
![]() USA
|
![]() Ardelyx
ARDX
|
$1.15 B |
-0.000 M
|
![]() USA
|
![]() Seres Therapeutics
MCRB
|
$64.51 M |
0.000 M
|
![]() USA
|
![]() Synlogic
SYBX
|
$12.40 M |
0.000 M
|
![]() USA
|
![]() Vaxart
VXRT
|
$78.48 M |
0.890 M
|
![]() USA
|
![]() Amarin Corporation
AMRN
|
$0.19 B |
-0.000 M
|
![]() Ireland
|
Market Cap | = | RANI Stock Price | * | RANI Shares Outstanding |
= | $1.17 | * | 33.57 M | |
= | $68.80 M |